|
Type 2 diabetes
Citations 241-250 of 286 total displayed.
|
Past content
(since Dec 2000):
|
- Scientific Contributions
Dopamine-Mediated Inhibition of Renal Na,K-ATPase Is Reduced by Insulin
- Anees Ahmad Banday, Mohammad Asghar, Tahir Hussain, and Mustafa F. Lokhandwala
Hypertension published April 21, 2003, doi:10.1161/01.HYP.0000069260.11830.CD
[Abstract]
- Editorial Commentary
Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Practical Implications
- Suzanne Oparil
Hypertension published April 14, 2003, doi:10.1161/01.HYP.0000070905.09395.F6
[Abstract]
- Scientific Contributions
Capillary Pressure in Subjects With Type 2 Diabetes and Hypertension and the Effect of Antihypertensive Therapy
- P. Gerard Fegan, John E. Tooke, Kim M. Gooding, Jayne M. Tullett, Kenneth M. MacLeod, and Angela C. Shore
Hypertension published April 14, 2003, doi:10.1161/01.HYP.0000068200.09187.1E
[Abstract]
- Scientific Contributions
Deficiency of Adrenomedullin Induces Insulin Resistance by Increasing Oxidative Stress
- Tatsuo Shimosawa, Takehide Ogihara, Hiromitsu Matsui, Tomoichiro Asano, Katsuyuki Ando, and Toshiro Fujita
Hypertension published March 31, 2003, doi:10.1161/01.HYP.0000066846.46422.2C
[Abstract]
- Scientific Contributions
Effect of Low-Dose Perindopril/Indapamide on Albuminuria in Diabetes. Preterax in Albuminuria Regression: PREMIER
- Carl Erik Mogensen, Giancarlo Viberti, Serge Halimi, Eberhard Ritz, Luis Ruilope, György Jermendy, Jiri Widimsky, Pinchas Sareli, Jan Taton, Juan Rull, Gürbüz Erdogan, Pieter W. De Leeuw, Arthur Ribeiro, Ramiro Sanchez, Rachid Mechmeche, John Nolan, Jana Sirotiakova, Ahmed Hamani, André Scheen, Bernhard Hess, Anton Luger, and Stephen M. Thomas
Hypertension published March 24, 2003, doi:10.1161/01.HYP.0000064943.51878.58
[Abstract]
- Scientific Contributions
Outcomes With Nifedipine GITS or Co-Amilozide in Hypertensive Diabetics and Nondiabetics in Intervention as a Goal in Hypertension (INSIGHT)
- Giuseppe Mancia, Morris Brown, Alain Castaigne, Peter de Leeuw, Christopher R. Palmer, Talma Rosenthal, Gilbert Wagener, and Luis M. Ruilope
Hypertension 2003;41:431-436; published online before print as doi:10.1161/01.HYP.0000057420.27692.AD
[Abstract]
[Full text]
- Novartis Lectures
The Kidney, Hypertension, and Obesity
- John E. Hall
Hypertension 2003;41:625-633; published online before print as doi:10.1161/01.HYP.0000052314.95497.78
[Abstract]
[Full text]
- Scientific Contributions
Outcomes With Nifedipine GITS or Co-Amilozide in Hypertensive Diabetics and Nondiabetics in Intervention as a Goal in Hypertension (INSIGHT)
- Giuseppe Mancia, Morris Brown, Alain Castaigne, Peter de Leeuw, Christopher R. Palmer, Talma Rosenthal, Gilbert Wagener, and Luis M. Ruilope
Hypertension published February 17, 2003, doi:10.1161/01.HYP.0000057420.27692.AD
[Abstract]
- Scientific Contributions
Effects of Isosorbide Mononitrate and AII Inhibition on Pulse Wave Reflection in Hypertension
- Gordon S. Stokes, Edward S. Barin, and Kerry L. Gilfillan
Hypertension 2003;41:297-301; published online before print as doi:10.1161/01.HYP.0000049622.07021.4F
[Abstract]
[Full text]
- Novartis Award Lecture
The Kidney, Hypertension, and Obesity
- John E. Hall
Hypertension published January 20, 2003, doi:10.1161/01.HYP.0000052314.95497.78
[Abstract]
|
|
